Hemodialysis Catheter-related Infections: Incidence, Microbiology and Outcome 5 years of Dubai Hospital Experience



Abstract Views
918

Downloads
498

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Jun 11, 2021
Published Jul 10, 2021
10.24018/clinicmed.2021.2.3.97

Abstract viewed = 918 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Background: The central venous catheters (CVC) has recently become a worldwide commonest technique for vascular access, however; prone to infection and associated with other complications more than other vascular access techniques, such as fistula or graft.

Objective: To investigate the incidence, the types of micro-organism, the most sensitive and suitable antibiotics, the outcomes associated with CVC infection in chronic hemodialysis patients treated through tunneled CVC.in a single-center population.

Methods: The records of hemodialysis patients from January 2012 to December 2016 were reviewed. Patients above 14 years of age, on hemodialysis via a permanent tunneled catheter at any time of the mentioned period, were included. The rate of CRBSI (Catheter-Related Blood Stream Infections) was calculated as density of incidence and reported per 1000 catheter days. Patient mortality was recorded.

Results: In 5 years, a total of 73 episodes of CRBSI in 49 hemodialysis patients were recorded. 59.2% were male with a mean age of 53.57 years. 40.8% had end-stage kidney disease secondary to diabetic nephropathy. In all, 67.3% episodes grew Gram-positive isolates, among those staphylococci epidermidis (26.4%, n=19) and staphylococci aureus (25%, n=18) were the most common organism, whereas Klebsiella pneumonia (8.3%, n=6), Enterobacter cloacae (8.3%, n=6), pseudomonas aeruginosa (5.5%, n=4) and E.coli (5.5%, n=4) were the most common Gram-negative isolates. A total of 6 isolates were multidrug-resistant, which includes Klebsiella pneumonia, Citrobacter, and E. coli. Only 1 out of 18 staphylococci aureus cases were methicillin-resistant and 21% (n=6) of Gram-negative isolates were Extended-spectrum beta-lactamase (ESBL) producing organisms. The average hospital stay was 9 days (2-30 days). The hemodialysis catheter was removed for 19 (38.77%) patients and 4 (8.1%) patients expired due to septic shock despite catheter removal and being on appropriate antibiotics.

Conclusion: The mainstay to reduce CRBSI would be ideal to avoid catheters or decrease the duration of catheters. This can be achieved through more aggressive counseling and fast-track protocols for AV Fistulae creation at the pre-dialysis stage.

Keywords: Catheter-Related Blood Stream Infections (CRBSIs), Central Venous Catheters (CVC), End-Stage Renal Disease, Hemodialysis

References

  1. Agarwal AK, Haddad NJ, Vachharajani TJ, Asif A. Innovations in vascular access for hemodialysis. Kidney Int. 2019 May;95(5):1053-63. doi: 10.1016/j.kint.2018.11.046.
     Google Scholar
  2. Arhuidese IJ, Orandi BJ, Nejim B, Malas M. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. J Vasc Surg. 2018 Oct; 68(4):1166-74.
     Google Scholar
  3. Allon M. Vascular access for hemodialysis patients: new data should guide decision making. Clin J Am Soc Nephrol. 2019 Jun 7;14(6):954-961. doi: 10.2215/CJN.00490119.
     Google Scholar
  4. Rodríguez-Aranda A, Alcazar JM, Sanz F, et al. Endoluminal colonization as a risk factor for coagulase-negative staphylococcal catheter-related bloodstream infections in hemodialysis patients. Nephrol Dial Transplant 2011; 26(3): 948–955.
     Google Scholar
  5. Gallieni M, Giordano A, Rossi U, Cariati M. Optimization of dialysis catheter function. J Vasc Access. 2016 Mar; 17 Suppl 1:S42-6.
     Google Scholar
  6. Bohlke M, Uliano G, Barcellos FC. Hemodialysis catheter-related infection: prophylaxis, diagnosis and treatment. J Vasc Access. 2015 Sep-Oct;16(5):347-55.
     Google Scholar
  7. McCann M, Einarsdottir H, Van Waeleghem JP, et al. Vascular access management III: central venous catheters. J Ren Care 2010; 36(1): 25–33.
     Google Scholar
  8. Dittmer ID, Sharp D, McNulty CA, et al. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 1999; 51: 34–39.
     Google Scholar
  9. Johnson WJ, Kurtz SB, Mitchell JC, et al. Results of treatment of hemodialysis center patients. Mayo Clin Proc 1984; 59: 669–671.
     Google Scholar
  10. Kovalik EC, Raymond JR, Albers FJ, et al. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol 1996; 7: 2264–2267.
     Google Scholar
  11. Kaur M, Gupta V, Gombar S, Chander J, Sahoo T. Incidence, risk factors, microbiology of venous catheter associated bloodstream infections-a prospective study from a tertiary care hospital. Indian J Med Microbiol. 2015 Apr-Jun;33(2):248-54.
     Google Scholar
  12. Napalkov P, Felici DM, Chu LK, et al. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC Cardiovasc Disord 2013; 13: 86.
     Google Scholar
  13. Taylor G, Gravel D, Johnston L, et al. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 2002; 23: 716–720.
     Google Scholar
  14. Gahlot R, Nigam C, Kumar V, et al. Catheter-related bloodstream infections. Int J Crit Illn Inj Sci 2014; 4(2): 162–167.
     Google Scholar
  15. Ibrahim M, Fahad R.A, Sumaiya I, et al. Hemodialysis catheter-related infections: Result of tertiary care center study in Saudi Arabia. Int J Med Sci Public Health 2019;8(4): 318-25.
     Google Scholar
  16. Amira M, Malik H.A, Khaled A.M, et al. Incidence of Central line associated blood stream infection in intensive care unit in private hospital (Cairo, Egypt). Open Publ Health J 2018; 11: 562-71.
     Google Scholar
  17. Leonard A.M, Michael A, Emilio B, et al. Clinical practice guidelines for diagnosis and management of intravascular catheter related infection: 2009 update by infectious disease society of America. Clinical infectious disease 2009; 49(1): (1-45).
     Google Scholar
  18. Haddadin Y, Annamaraju P, Regunath H. Central line associated blood stream infections (CLABSI). StatPearls [Internet]. 2020 Jun 22. Accessed on Jan 2021.
     Google Scholar
  19. https://www.dbth.nhs.uk/wp-content/uploads/2017/12/CRBSI-final.pdf. Accessed on Jan 2021.
     Google Scholar
  20. https://www.cdc.gov/infectioncontrol/pdf/guidelines/bsi-guidelines-H.pdf Accessed on Jan 2021.
     Google Scholar
  21. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, Allon M, Asif A, Astor BC, Glickman MH, Graham J. KDOQI clinical practice guideline for vascular access: 2019 update. American Journal of Kidney Diseases. 2020 Apr 1;75(4):S1-64.
     Google Scholar
  22. Bolton WK. Renal Physicians Association Clinical Practice Guideline: Appropriate Patient Preparation for Renal Replacement Therapy: Guideline Number 3. Journal of the American Society of Nephrology. 2003 May 1;14(5):1406-10.
     Google Scholar
  23. Vassalotti JA, Jennings WC, Beathard GA, Neumann M, Caponi S, Fox CH, et al. Fistula first breakthrough initiative: targeting catheter last in fistula first. Semin Dial. 2012;25(3):303–10.
     Google Scholar
  24. de Pinho NA, Coscas R, Metzger M, Labeeuw M, Ayav C, Jacquelinet C, Massy ZA, Stengel B. Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study. BMC nephrology. 2017 Dec;18(1):1-1.
     Google Scholar
  25. Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zarkowsky DS, Qazi U, et al. Trends in incident hemodialysis access and mortality. JAMA Surg. 2015;150(5):441–8.
     Google Scholar
  26. Noordzij M, Jager KJ, van der Veer SN, Kramar R, Collart F, Heaf JG, et al. Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry. Nephrol Dial Transplant. 2014;29(10):1956–64.
     Google Scholar
  27. Allon M. Dialysis catheter-related bacteraemia: treatment and prophylaxis. Am J Kidney Dis 2004;44(5):779-91.
     Google Scholar
  28. Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in haemodialysis patients. Kidney international. 2011;79(6):587-98.
     Google Scholar
  29. Betjes MG. Prevention of catheter-related bloodstream infection in patients on haemodialysis. Nature reviews. Nephrology. 2011;7(5):257-65.
     Google Scholar
  30. Shefali G, Shrikara P.M, Ashok B, Shrikala B. Microbiology of Non-tunneled catheter related infections. 2016;10(7):24-8.
     Google Scholar
  31. Hao Y.Y, Shu C.P, Chei S.T, et al. Catheter related complications and survival among incident hemodialysis patients in Singapore. J Vasc Access. 201819(6):602-08.
     Google Scholar


Most read articles by the same author(s)